pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-6132 |
Genomic Coordinates | chr7: 117020211 - 117020319 |
Description | Homo sapiens miR-6132 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-6132 | |||||||||||||||
Sequence | 21| AGCAGGGCUGGGGAUUGCA |39 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | LY6E | ||||||||||||||||||||
Synonyms | RIG-E, RIGE, SCA-2, SCA2, TSA-1 | ||||||||||||||||||||
Description | lymphocyte antigen 6 family member E | ||||||||||||||||||||
Transcript | NM_001127213 | ||||||||||||||||||||
Other Transcripts | NM_002346 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on LY6E | |||||||||||||||||||||
3'UTR of LY6E (miRNA target sites are highlighted) |
>LY6E|NM_001127213|3'UTR 1 CCGCCCAGACCCTGTCCCCCGATCCCCCAGCTCAGGAAGGAAAGCCCAGCCCTTTCTGGATCCCACAGTGTATGGGAGCC 81 CCTGACTCCTCACGTGCCTGATCTGTGCCCTTGGTCCCAGGTCAGGCCCACCCCCTGCACCTCCACCTGCCCCAGCCCCT 161 GCCTCTGCCCCAAGTGGGGCCAGCTGCCCTCACTTCTGGGGTGGATGATGTGACCTTCCTTGGGGGACTGCGGAAGGGAC 241 GAGGGTTCCCTGGAGTCTTACGGTCCAACATCAGGACCAAGTCCCATGGACATGCTGACAGGGTCCCCAGGGAGACCGTG 321 TCAGTAGGGATGTGTGCCTGGCTGTGTACGTGGGTGTGCAGTGCACGTGAGAGCACGTGGCGGCTTCTGGGGGCCATGTT 401 TGGGGAGGGAGGTGTGCCAGCAGCCTGGAGAGCCTCAGTCCCTGTAGCCCCCTGCCCTGGCACAGCTGCATGCACTTCAA 481 GGGCAGCCTTTGGGGGTTGGGGTTTCTGCCACTTCCGGGTCTAGGCCCTGCCCCAAATCCAGCCAGTCCTGCCCCAGCCC 561 ACCCCCACATTGGAGCCCTCCTGCTGCTTTGGTGCCTCAAATAAATACAGATGTCCCCCAGAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 4061.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1065669 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_8 |
Location of target site | ENST00000517503.1 | 3UTR | ACCCCCUGCACCUCCACCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000517503.1 | 3UTR | CCCACCCCCUGCACCUCCACCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
82 hsa-miR-6132 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT067294 | NECAP1 | NECAP endocytosis associated 1 | 2 | 10 | ||||||||
MIRT100110 | ABT1 | activator of basal transcription 1 | 2 | 8 | ||||||||
MIRT358583 | CANX | calnexin | 2 | 2 | ||||||||
MIRT445247 | SEMA5A | semaphorin 5A | 2 | 2 | ||||||||
MIRT445764 | CCND3 | cyclin D3 | 2 | 2 | ||||||||
MIRT452388 | LY6E | lymphocyte antigen 6 family member E | 2 | 4 | ||||||||
MIRT452829 | FAM131B | family with sequence similarity 131 member B | 2 | 2 | ||||||||
MIRT453450 | GLG1 | golgi glycoprotein 1 | 2 | 2 | ||||||||
MIRT455435 | ID3 | inhibitor of DNA binding 3, HLH protein | 2 | 2 | ||||||||
MIRT460629 | IGFBP4 | insulin like growth factor binding protein 4 | 2 | 2 | ||||||||
MIRT461607 | DPH2 | DPH2 homolog | 2 | 2 | ||||||||
MIRT461989 | PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 2 | 2 | ||||||||
MIRT464258 | VCL | vinculin | 2 | 2 | ||||||||
MIRT465713 | TNFAIP1 | TNF alpha induced protein 1 | 2 | 2 | ||||||||
MIRT466475 | TECPR2 | tectonin beta-propeller repeat containing 2 | 2 | 7 | ||||||||
MIRT467119 | SRGAP1 | SLIT-ROBO Rho GTPase activating protein 1 | 2 | 4 | ||||||||
MIRT468299 | SFT2D2 | SFT2 domain containing 2 | 2 | 2 | ||||||||
MIRT469696 | RAB5B | RAB5B, member RAS oncogene family | 2 | 8 | ||||||||
MIRT469904 | PTRF | caveolae associated protein 1 | 2 | 2 | ||||||||
MIRT470015 | PTPLB | 3-hydroxyacyl-CoA dehydratase 2 | 1 | 1 | ||||||||
MIRT471385 | PDPR | pyruvate dehydrogenase phosphatase regulatory subunit | 2 | 2 | ||||||||
MIRT471409 | PDP2 | pyruvate dehyrogenase phosphatase catalytic subunit 2 | 2 | 2 | ||||||||
MIRT471719 | OTUB1 | OTU deubiquitinase, ubiquitin aldehyde binding 1 | 2 | 2 | ||||||||
MIRT473608 | MARK2 | microtubule affinity regulating kinase 2 | 2 | 2 | ||||||||
MIRT476328 | GLTSCR1L | BRD4 interacting chromatin remodeling complex associated protein like | 2 | 2 | ||||||||
MIRT479448 | CDK6 | cyclin dependent kinase 6 | 2 | 2 | ||||||||
MIRT482032 | AMER1 | APC membrane recruitment protein 1 | 2 | 2 | ||||||||
MIRT482360 | AGO2 | argonaute 2, RISC catalytic component | 2 | 2 | ||||||||
MIRT484661 | HOXD3 | homeobox D3 | 2 | 4 | ||||||||
MIRT486828 | NDOR1 | NADPH dependent diflavin oxidoreductase 1 | 2 | 2 | ||||||||
MIRT487069 | CLASP1 | cytoplasmic linker associated protein 1 | 2 | 4 | ||||||||
MIRT487196 | NFASC | neurofascin | 2 | 4 | ||||||||
MIRT487448 | TFAP2B | transcription factor AP-2 beta | 2 | 4 | ||||||||
MIRT487517 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT487640 | BRSK2 | BR serine/threonine kinase 2 | 2 | 4 | ||||||||
MIRT487755 | SKI | SKI proto-oncogene | 2 | 4 | ||||||||
MIRT489944 | CPLX1 | complexin 1 | 2 | 2 | ||||||||
MIRT491101 | MSI1 | musashi RNA binding protein 1 | 2 | 4 | ||||||||
MIRT491181 | LAMA5 | laminin subunit alpha 5 | 2 | 2 | ||||||||
MIRT492355 | SEMA7A | semaphorin 7A (John Milton Hagen blood group) | 2 | 2 | ||||||||
MIRT493918 | FAM127B | retrotransposon Gag like 8A | 2 | 4 | ||||||||
MIRT493932 | FAM127A | retrotransposon Gag like 8C | 2 | 4 | ||||||||
MIRT494679 | ARID3A | AT-rich interaction domain 3A | 2 | 2 | ||||||||
MIRT494814 | AKAP11 | A-kinase anchoring protein 11 | 2 | 2 | ||||||||
MIRT494835 | ADCY9 | adenylate cyclase 9 | 2 | 2 | ||||||||
MIRT495455 | PNMAL2 | paraneoplastic Ma antigen family member 8B | 2 | 2 | ||||||||
MIRT496962 | MAP1LC3B | microtubule associated protein 1 light chain 3 beta | 2 | 2 | ||||||||
MIRT526228 | MTRNR2L5 | MT-RNR2-like 5 | 2 | 2 | ||||||||
MIRT531028 | TDGF1P3 | teratocarcinoma-derived growth factor 1 pseudogene 3 | 2 | 2 | ||||||||
MIRT557110 | HOXA3 | homeobox A3 | 2 | 2 | ||||||||
MIRT560514 | POGK | pogo transposable element derived with KRAB domain | 2 | 2 | ||||||||
MIRT567753 | DLC1 | DLC1 Rho GTPase activating protein | 2 | 2 | ||||||||
MIRT569608 | TRIM29 | tripartite motif containing 29 | 2 | 2 | ||||||||
MIRT570242 | CPNE5 | copine 5 | 2 | 2 | ||||||||
MIRT572327 | HSPB6 | heat shock protein family B (small) member 6 | 2 | 2 | ||||||||
MIRT572373 | ATOX1 | antioxidant 1 copper chaperone | 2 | 2 | ||||||||
MIRT575024 | Tecpr2 | tectonin beta-propeller repeat containing 2 | 2 | 5 | ||||||||
MIRT576146 | Hmox1 | heme oxygenase 1 | 2 | 2 | ||||||||
MIRT612443 | SMOC2 | SPARC related modular calcium binding 2 | 2 | 2 | ||||||||
MIRT615404 | VDAC2 | voltage dependent anion channel 2 | 2 | 2 | ||||||||
MIRT629114 | CYCS | cytochrome c, somatic | 2 | 2 | ||||||||
MIRT631362 | FOXI2 | forkhead box I2 | 2 | 2 | ||||||||
MIRT639322 | THBD | thrombomodulin | 2 | 2 | ||||||||
MIRT643797 | ABCC12 | ATP binding cassette subfamily C member 12 | 2 | 2 | ||||||||
MIRT669687 | ABLIM1 | actin binding LIM protein 1 | 2 | 2 | ||||||||
MIRT670595 | LLGL1 | LLGL1, scribble cell polarity complex component | 2 | 4 | ||||||||
MIRT691190 | NIF3L1 | NGG1 interacting factor 3 like 1 | 2 | 2 | ||||||||
MIRT691688 | FLOT2 | flotillin 2 | 2 | 2 | ||||||||
MIRT697127 | OTUD5 | OTU deubiquitinase 5 | 2 | 2 | ||||||||
MIRT700814 | PHLDA2 | pleckstrin homology like domain family A member 2 | 2 | 2 | ||||||||
MIRT701248 | NUP35 | nucleoporin 35 | 2 | 2 | ||||||||
MIRT702362 | KLHL15 | kelch like family member 15 | 2 | 2 | ||||||||
MIRT703325 | GDPD5 | glycerophosphodiester phosphodiesterase domain containing 5 | 2 | 2 | ||||||||
MIRT706060 | PKD1 | polycystin 1, transient receptor potential channel interacting | 2 | 2 | ||||||||
MIRT710475 | CDH5 | cadherin 5 | 2 | 2 | ||||||||
MIRT713018 | SLC4A2 | solute carrier family 4 member 2 | 2 | 2 | ||||||||
MIRT716427 | RAB15 | RAB15, member RAS oncogene family | 2 | 2 | ||||||||
MIRT718093 | ABHD12 | abhydrolase domain containing 12 | 2 | 2 | ||||||||
MIRT718542 | PIGQ | phosphatidylinositol glycan anchor biosynthesis class Q | 2 | 2 | ||||||||
MIRT719122 | CACFD1 | calcium channel flower domain containing 1 | 2 | 2 | ||||||||
MIRT721393 | LDLRAD4 | low density lipoprotein receptor class A domain containing 4 | 2 | 2 | ||||||||
MIRT736283 | CDC42 | cell division cycle 42 | 2 | 0 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|